Folate‐Targeted Liposomal Co‐Delivery of Methotrexate and Antisense HULC for Colorectal Cancer: In Vitro Therapeutic Evaluation
Colorectal cancer is mentioned as the third most common type of diagnosed malignancy worldwide. Therefore, a novel folic acid (FA)‐functionalized liposomal nanocarriers containing methotrexate (MTX) and antisense lncRNA HULC were developed against HCT116 colorectal cancer cells. The fabricated nanocarrier (LDT‐A) w...